Definition of the binding mode of phosphoinositide 3-kinase α-selective inhibitor A-66S through molecular dynamics

Xiaoli Bian1, Wangqing Dong, Yang Zhao

  • 1Department of Pharmacy, College of Medicine, Xi'an Jiaotong University, No. 76 Yanta west Road, Xi'an, 710061, People's Republic of China.

Insights

This study reveals how A-66S, a selective phosphatidylinositol 3-kinase alpha (PI3Kα) inhibitor, binds to PI3Kα. Key hydrophobic and hydrogen-bond interactions, particularly with Gln859, drive its potent and selective anticancer activity.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Phosphatidylinositol 3-kinase alpha (PI3Kα) activation is crucial for cancer progression.
  • PI3Kα is a significant target for developing novel anticancer therapeutics.

Purpose of the Study:

  • To elucidate the binding mode of A-66S, a selective PI3Kα inhibitor.
  • To understand the molecular interactions responsible for A-66S's efficacy and selectivity.

Main Methods:

  • Molecular docking simulations.
  • Molecular dynamics (MD) simulations.
  • Energetic analysis using MMPBSA and MMGBSA.

Main Results:

  • A-66S exhibits strong binding affinity to PI3Kα, with binding free energies of -11.27 kcal•mol⁻¹ (MMPBSA) and -14.67 kcal•mol⁻¹ (MMGBSA).
  • Hydrophobic and electrostatic interactions are critical for binding, involving the adenine region of PI3Kα and the bithiazol moiety of A-66S.
  • Specific hydrogen bonds and interactions with non-conserved residue Gln859 contribute to A-66S's selectivity for PI3Kα.

Conclusions:

  • The detailed binding mode of A-66S to PI3Kα has been characterized.
  • Understanding these interactions can guide the design of more potent and selective PI3Kα inhibitors for cancer therapy.

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
7.7K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
10.6K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
2.1K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
12.1K
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
11.9K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K